These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 6379061

  • 1. Absolute requirement for complement in monoclonal IgM antibody-mediated protection against experimental infection with type III group B streptococci.
    Shigeoka AO, Jensen CL, Pincus SH, Hill HR.
    J Infect Dis; 1984 Jul; 150(1):63-70. PubMed ID: 6379061
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An IgA monoclonal antibody directed against type III antigen on group B streptococci acts as an opsonin.
    Bohnsack JF, Hawley MM, Pritchard DG, Egan ML, Shigeoka AO, Yang KD, Hill HR.
    J Immunol; 1989 Nov 15; 143(10):3338-42. PubMed ID: 2681414
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1.
    Raff HV, Bradley C, Brady W, Donaldson K, Lipsich L, Maloney G, Shuford W, Walls M, Ward P, Wolff E.
    J Infect Dis; 1991 Feb 15; 163(2):346-54. PubMed ID: 1988519
    [Abstract] [Full Text] [Related]

  • 9. Opsonic activity of human IgG and IgM antibody for type III group B streptococci.
    Anthony BF, Concepcion NF.
    Pediatr Res; 1989 Oct 15; 26(4):383-7. PubMed ID: 2677951
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Class specificity of naturally acquired and vaccine-induced antibody to type III group B streptococcal capsular polysaccharide: determination with a radioimmunoprecipitin assay.
    Edwards MS, Fuselier PA, Rench MA, Kasper DL, Baker CJ.
    Infect Immun; 1984 May 15; 44(2):257-61. PubMed ID: 6370863
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative protective activity of human monoclonal and hyperimmune polyclonal antibody against group B streptococci.
    Hill HR, Gonzales LA, Knappe WA, Fischer GW, Kelsey DK, Raff HV.
    J Infect Dis; 1991 Apr 15; 163(4):792-8. PubMed ID: 2010632
    [Abstract] [Full Text] [Related]

  • 18. Type-specific monoclonal antibody enhances the local phagocytic response to group B streptococcal infection.
    Shigeoka AO, Weber ME, Pincus SH, Pritchard DG, Egan ML, Hill HR.
    J Infect Dis; 1986 Jun 15; 153(6):1170-3. PubMed ID: 3517190
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.